2017
DOI: 10.17116/jnevro201711710138-43
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation of efficiency and safety of adding neuromultivit to basic therapy of vertebrogenic radiculopathy

Abstract: Addition of neuromultivit to basic therapy increased the efficacy of treatment of VR L5-S1.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(1 citation statement)
references
References 3 publications
0
1
0
Order By: Relevance
“…The selective inhibitor of COX1 and COX2, celecoxib, and the moderately selective inhibitor of COX1 and selective COX2, meloxicam, have a positive effect on nonspecific OPS in the lower back [2,7,8]. The question arises about the advisability of prescribing vitamin complexes (group B) in combination with NSAIDs in the treatment of nonspecific OPS in the lower back [5,9,10].…”
Section: Relevancementioning
confidence: 99%
“…The selective inhibitor of COX1 and COX2, celecoxib, and the moderately selective inhibitor of COX1 and selective COX2, meloxicam, have a positive effect on nonspecific OPS in the lower back [2,7,8]. The question arises about the advisability of prescribing vitamin complexes (group B) in combination with NSAIDs in the treatment of nonspecific OPS in the lower back [5,9,10].…”
Section: Relevancementioning
confidence: 99%